Xiao Ding

机构：Guangzhou Academy of Fine Arts, Zhejiang Medicine (China) · ORCID：0000-0002-2792-3484

发表论文 33 篇 · 总被引 687 次 · h-index 8

代表论文

• The role of cholesterol metabolism in cancer. (2019 · PubMed · 被引 307)
• Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors (2025 · Nature Biotechnology · 被引 68)
• Multi-cohort analysis reveals colorectal cancer tumor location-associated fecal microbiota and their clinical impact (2025 · Cell Host & Microbe · 被引 33)
• Histologic transformation of non-small-cell lung cancer in brain metastases (2018 · International Journal of Clinical Oncology · 被引 17)
• Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers (2024 · Cancer Research · 被引 10)
• Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS (2024 · arXiv (Cornell University) · 被引 9)